1 CNRU, Department of Communication and Psychology, Kroghsstraede 3, 9220 Aalborg, Aalborg University, Denmark 2 CNRU, CFIN, MindLab, Hammel Neurorehabilitation and Research Centre, Noerrebrogade 44, 8000 Aarhus C, Aarhus University, Denmark 3 Section for Philosophy, Department of Media, Cognition and Communication, University of Copenhagen, Njalsgade 80, 2300 Copenhagen S, Denmark 4 Danish Nat...

Regarding the Covid-19 pandemic, researchers continue to be concerned about topics that have not yet been elucidated, complications of serious patients during and after COVID, as well their relationship with vaccination, are interesting. Studies show good acceptance vaccine by general population, however, 15-20% doubts its safety. The most frequent pulmonary, extrapulmonary neurological, latter...

celiac disease or gluten sensitivity may initially present as one or more neurological signs and/or symptoms. on the other hand, it may be associated with or complicated by neurological manifestations. neurological presentations are rare in children but as many as 36% of adult patients present with neurological changes. with severe malnutrition after progression of celiac disease, different vit...

Clinical neurology has been traditionally considered as an academic speciality in which the specialist regurgitates his/her knowledge of neurology without being able to do much for the patient. This attitude is no longer acceptable. Surge of information and discoveries in neurosciences within the last two decades translated into therapeutic interventions which is literally life saving in some o...

MicroRNAs (miRNAs) are a class of small, well-conserved noncoding RNAs that regulate gene expression post-transcriptionally. They have been demonstrated to regulate a lot of biological pathways and cellular functions. Many miRNAs are dynamically regulated during central nervous system (CNS) development and are spatially expressed in adult brain indicating their essential roles in neural develop...

no abstract

Neuronal plasticity is an essential property of the brain that is impaired in different neurological conditions. Phosphodiesterase type 1 (PDE1) inhibitors can enhance levels of the second messengers cAMP/cGMP leading to the expression of neuronal plasticity-related genes, neurotrophic factors, and neuroprotective molecules. These neuronal plasticity enhancement properties make PDE1 inhibitors ...

[This corrects the article on p. 284 in vol. 10, PMID: 27445739.].